Excellent Outcome for Pediatric Patients with High Risk Hodgkin Lymphoma with Brentuximab Vedotin and Risk Adapted Residual Node Radiation
Year: 2020
Type: preprint
Study design: Clinical Trial
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.3716895
Authors: Monika Metzger, Michael P. Link, Amy L. Billett, Jamie Flerlage, John T. Lucas Jr., Belinda N. Mandrell, Matthew J. Ehrhardt, Nickhill Bhakta, Torunn I. Yock, Alison M. Friedmann, Pedro de Alarcon, Sandra Luna-Fineman, Eric Larsen, Sue C. Kaste, Barry L. Shulkin, Zhaohua Lu, Chen Li, Susan M. Hinike, Sarah S. Donaldson, Melissa M. Hudson, Matthew J. Krasin
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3162373211